Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
2014 ◽
Vol 20
(2)
◽
pp. S180
◽
2013 ◽
Vol 31
(8)
◽
pp. 743-753
◽
2002 ◽
Vol 34
(8)
◽
pp. 3378-3383
◽
2016 ◽
Vol 22
(3)
◽
pp. S249